Introduction
============

*Campylobacter jejuni* has been recognized as one of the most important pathogens, which can cause infectious diarrhea and severe forms of disease such as Guillain-Barre Syndrome or Miller Fischer Syndrome ([@B41]; [@B24]; [@B39]). The CDC estimated that in 2009 the number of *Campylobacter* infection was 13.02 per 100,000 people ([@B43]). The cost of human Campylobacteriosis in the United States is estimated at \$1.3 to 6.8 billion dollars annually ([@B42]; [@B9]). Macrolides (e.g., erythromycin) are the most important drugs of choice for clinical treatment of *Campylobacter* infections ([@B13]). Unfortunately, macrolides-resistant *Campylobacter* have emerged and impose a global public health concerns ([@B14]; [@B8]). In earlier study we demonstrated that the transcription level of *Cj0440c* was increased in high-level erythromycin-resistant *C. jejuni* ([@B22]).

Bioinformatic analyses suggested that *Cj0440c* is a putative transcriptional regulator and encodes a TENA/THI-4 family protein, however, the molecular function of this family is yet to be determined. The gene *Cj0440c* is located downstream of the *Cj0437--Cj0439* operon *(mfr*, methylmenaquinol:fumarate reductase) which plays an important role in the susceptibility to hydrogen peroxide (H~2~O~2~) ([@B38]; [@B51]; [@B29]) and upstream of *Cj0441* (*acpP*, acyl carrier protein) which is a universal and highly conserved acyl donor for synthesis of fatty acid, endotoxin and acylated homoserine lactones for the quorum sensing in *C. jejuni* ([@B5]). Both the downstream and upstream genes of *Cj0440c* were essential for the growth, survival, colonization and pathogenesis in *Campylobacter.* Although *Cj0440c* is located on the opposite DNA coding strand, it may divergently transcribed with its up-and-downstream genes, and likely to act as a transcriptional regulator and play an important role in gene regulation and the biological function in *C. jejuni*. The biological functions of *Cj0440c* in *C. jejuni* are largely unknown.

In the present study, *Cj0440c*-inactivated mutation was constructed in both erythromycin-susceptible (S) and -resistant *C. jejuni* (R), the transcriptional profile and relative *in vitro* and *in vivo* phenotype determination were implemented to decipher the function and regulation mechanism of *Cj0440c.*

Materials and Methods {#s1}
=====================

Plasmids, Bacterial Strains, and Growth Conditions
--------------------------------------------------

The *C. jejuni* NCTC11168 (designated as **S**) was kindly provided by Chinese Center for Disease Control and Prevention. *C. jejuni* strains were routinely cultured in Mueller-Hinton (MH) medium at 42°C under microaerobic conditions (5% O~2~, 10% CO~2~, and 85% N~2~) in the anaerobic incubator (YQX-II, Shanghai, China) ([@B33]). The *Escherichia coli* DH5α was grown aerobically in Luria-Bertani medium at 37°C. The erythromycin-resistant *C. jejuni* strain 68-ER (designated as **R**) was descendant of *C. jejuni* NCTC11168 resulting from *in vitro* step-wise selection by erythromycin. Plasmids pGEM-T (Promega, Madison, WI, USA) and pMW10 was kindly provided by China Agricultural University and used for mutant vector construction.

Construction of Isogenic Δ*Cj0440c* Mutants
-------------------------------------------

The DNA fragment containing *Cj0440c* gene and its flanking regions was amplified from *C. jejuni* NCTC 11168 genome using *Pfu* polymerase (Promega) with primers of Cj0440cF~2~ and Cj0440cR~2~ (**Table [1](#T1){ref-type="table"}**) and was cloned into pGEM-T easy vector (Promega,) to generate plasmid pCJ0440c. Primers pCj0440cU and pCj0440cL (**Table [1](#T1){ref-type="table"}**) carrying endonuclease restriction sites of KpnI and XbaI were used to inversely amplify DNA fragment from the vector of pCJ0440c using Taq and Pfu polymerase (8:1). A kanamycin resistance cassette (*kan*) was amplified from pMW10 plasmid with Pfu polymerase (Promega) using primers KanF and KanR (**Table [1](#T1){ref-type="table"}**) which have the same restriction sites of KpnI and XbaI. The amplified DNA fragments of inverse PCR and *kan* were digested with KpnI and XbaI and purified with a PCR clean-up kit (Generay, Shanghai, China). The digested inverse PCR product was ligated to the *kan* cassette using T4 DNA ligase (Takara, Dalian, China) to obtain the construct plasmid pCJ0440c-Kan, which was then transformed into *E. coli* DH5α. The purified plasmid of pCJ0440c-Kan was introduced into S and R via electroporation according to the method described previously ([@B25]). Insertional mutants, named SM and RM, respectively, were selected on MH agar plates with 25 μg/ml kanamycin and 50 μg/ml ampicillin. Both PCR and sequencing analysis of the *Cj0440c* mutants (SM and RM) confirmed that the mutation resulted in deletion of 200 bp of coding sequence in *Cj0440c* and simultaneous insertion of the *kan* gene into the same location.

###### 

Primers used for construction of *Cj0440c* mutant and for real-time qPCR.

  Primer name                                                          Primer Sequence (from 5′ to 3′)                   Productsize (bp)
  -------------------------------------------------------------------- ------------------------------------------------- ------------------
  Primers used for construction and confirmation of *Cj0440c* mutant                                                     
  Cj0440c-F2                                                           AATACCAGAAGCCGAAAC                                2315
  Cj0440c-R2                                                           GAGGGTGAAATAGAAGGG                                
  pCj0440c-U                                                           GG[GGTACC]{.ul}AGATCATCCTTACAAGGAAT *Kpn*I site   5100
  pCj0440c-L                                                           GC[TCTAGA]{.ul}TTCATAGCAAAACGAAGT *Xba*I site     
  Kan-F                                                                GC[TCTAGA]{.ul}AATGGGCAAAGCAT *Xba*I site         1203
  Kan-R                                                                GG[GGTACC]{.ul}ATAATGCTAAGACAAT *Kpn*I site       
  Primers used for real-time qPCR                                                                                        
  Cj1339cF                                                             TCCATTAAACGGTTGATATCTGCTT                         125
  Cj1339cR                                                             AAGGCTATGGATGAGCAACTTAAAAT                        
  Cj1328F                                                              CTTTTAGCGATGCTTTTGAAGACTTA                        126
  Cj1328R                                                              CGCCACATAAATGCACTAAAGG                            
  Cj1294F                                                              GGCGTAAAACACGCTTGTGTATT                           79
  Cj1294R                                                              TTTCTTGGACACCTAGTGCTGTGTA                         
  Cj1338cF                                                             TTACCATTGTTGATAGCTTGACCTAAA                       75
  Cj1338cR                                                             TGCTTCAGGGATGGCGATA                               
  Cj0043F                                                              GGGTTCTCCTGTTGCAAGTGA                             75
  Cj0043R                                                              GCCCCTAAAACCCCAAAAAAT                             
  Cj0697F                                                              TGGTTCAGACCAAAGATGGA                              138
  Cj0697R                                                              TGCCAGCATTCTGAGGATTA                              
  Cj1242F                                                              AAGACATTGATCTTGGTGCTG                             143
  Cj1242R                                                              ATTGTTTGTGGCATTTCCTG                              
  Cj1385F                                                              GGAAACTGGGACTTGGTAGGAA                            83
  Cj1385R                                                              TGAGTATGGATGAAATCAGGGAATT                         
  Cj1464F                                                              CGAGTAAAATCGCAGAGCAG                              69
  Cj1464R                                                              TCGCAGCAGCTGTAGCTTT                               
  q16SF                                                                GCTCGTGTCGTGAGATGTTG                              199
  q16SR                                                                GCGGTATTGCGTCTCATTGTAT                            

RNA Microarray and Data Analysis
--------------------------------

The transcriptional difference between *Cj0440c* mutants and their parental strains (SM&S and RM&R) was examined by microarray (CapitalBio Corporation, Shanghai, China). Briefly, the strains were separately grown in MH broth for 24 h at 42°C under microaerophilic conditions with shaking. Immediately after the incubation, twice volume of RNA protective reagent (Qiagen, Germantown, MD, USA) was added to the culture (with same OD~600~ of 0.3) to stabilize mRNA. The total RNA from each sample was extracted using RNeasy Protect Mini Kit (Qiagen) and purified using Nucleo^®^Spin RNA clean-up kit (Macherey-nagel, Germany). The RNA quality and quantity was determined by formaldehyde denatured gel electrophoresis and Nanodrop^TM^ 2000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The cDNA was synthesized from the extracted RNA using iScript cDNA synthesis kit (Bio-Rad, Hercules, CA, USA). The cDNA was labeled by Cy5 or Cy3 dye and co-hybridized onto one microarray slide (NimbleGen 4 K × 72K), scanned by Axon Instruments Gene Pix 4000B (Union City, CA, USA) and read by Gene Pix Pro 6.0 (Axon Instruments). Microarray data were analyzed using Array Star software. The genes with False Discovery Rate (FDR)-corrected *q*-values \< 0.01 and fold change \>2 were selected as differentially expressed genes and subjected to NCBI gene annotation, KEGG pathway analysis and STRING 9.05 protein network analysis.

Microarray Data Accession Number
--------------------------------

The microarray data obtained in this study have been deposited in the NCBI Gene Expression Omnibus database^[1](#fn01){ref-type="fn"}^ and assigned accession number [GSE49255](GSE49255) and [GSE49256](GSE49256).

qRT-PCR
-------

The same batches cDNA of *Cj0440c* mutants (SM and RM) and their parental strains (S and R) used in microarray were subjected to qRT-PCR analysis to confirm the transcriptional difference of some respective genes identified by microarray following method described in previous study ([@B20]). Briefly, the PCR amplification was performed in IQ5 Multicolor Real-time PCR Detection System (Bio-Rad). The cycling conditions were as follows: 3 min of pre-incubation at 95°C, followed by 30 cycles of 10 s at 95°C and 40 s at 60°C. The primer sets used for specific genes are listed in **Table [1](#T1){ref-type="table"}**. 16S rDNA was used as an internal control for normalization. The experiment was done in triplicate to obtain the average value of fold change. The student's *t*-test was performed to analyze the significant difference between mutants and their parental stains.

Antimicrobial Susceptibility Test
---------------------------------

Minimum inhibitory concentrations (MICs) of nine antimicrobial agents (azithromycin, erythromycin, tylosin, ciprofloxacin, olaquindox, chloromycetin, tetracycline, gentamicin, and ceftriaxone) were determined using agar dilution method recommended by Clinical and Laboratory Standards Institute (CLSI). *C. jejuni* ATCC 33560 was used as a quality control strain.

Transmission Electron Microscopy
--------------------------------

The presence and length of flagella on the four *C. jejuni* strains (S, SM, R and RM) were examined using transmission electron microscopy according to a previously described method ([@B3]; [@B34]). Briefly, bacterial suspensions were obtained after washing plate with 2 ml sterile phosphate-buffered saline and spotted on carbon-coated copper grids. The cells were stained with 2% phosphotungstic acid (pH 6.7) for 1 min. Samples were observed employing a HITACHI H-7650 transmission electron microscope (Hitachi, Japan).

*In Vitro* Growth Determination
-------------------------------

To compare the growth kinetics of the mutants with that of the parental strains, a fresh culture (100 μL) of each *C. jejuni* strain (0.5 McFarland) was inoculated into 100 mL MH broth and the cultures were incubated at 42°C under microaerobic conditions for 36 h with shaking. The growth kinetics was determined by measuring the absorbance in 600 nm (OD~600~) at 0, 4, 8, 12, 20, 22, 24, 27, 31, 33, and 36 h post-inoculation.

Single and Competitive Colonization in Chicken
----------------------------------------------

Newly hatched broiler chickens (White Leghorns) were purchased from Zhengda Limited Company (Wuhan, China). All the broiler chickens were examined for *C. jejuni* to ascertain that birds are free of *C. jejuni* prior to infection all the chickens ([@B21]).

These chickens were randomly assigned to seven groups with 6 to 10 chickens per group. One group was used as a control. Four groups were used for single colonization test in which 10^9^ CFU *C. jejuni* strains (S, SM, R and RM) were individually inoculated via oral gavage into each group. Another two groups were used for pairwise competition test in which 10^9^ CFU *C. jejuni* pairwise mixtures (S&SM or R&RM) were inoculated via oral gavage to each group. Fecal samples were collected from each bird at 3, 6, 9, and 12 days' post-infection. The CFU of S, SM, R and RM were determined using *Campylobacter* selective CCDA agar (Oxoid, Thermo Fisher Scientific, Waltham, MA, USA) with or without 25 μg/ml Kanamycin or 50 μg/ml erythromycin. Each sample was spread onto three respective selective plates to obtain the average CFU.

The significance of differences between mutant and parental strain in colonization at each sampling time point was determined by using Student's *t*-test, Welch's *t*-test to allow for non-constant variation across treatment groups, and the Wilcoxon rank-sum test to allow for non-normality ([@B18]; [@B32]; [@B53]). Differences were considered significant at a *P*-value of \<0.01.

Ethics Statement
----------------

The animal study was approved by Animal Ethics Committee of Huazhong Agricultural University (HZAUCH 2013-002) and the Animal Care Center, Hubei Science and Technology Agency in China (SYXK 2013-0044). All experimental procedures in this study were performed according to the guidelines of the committee on the use and care of the laboratory animals in Hubei Province, China. All the animals were monitored throughout the study for any signs of adverse effects.

Results
=======

Differentially Expressed Genes in SM and RM
-------------------------------------------

The target gene *Cj0440c* was down-regulated in the *Cj0440c*-inactivated mutants (SM and RM). The other differentially expressed genes in *Cj0440c* mutants (SM and RM) compared to their parental strains (S and R) were shown in **Tables [2](#T2){ref-type="table"}**, **[3](#T3){ref-type="table"}**. The relationship of these different genes was summarized in **Figure [1](#F1){ref-type="fig"}**.

###### 

Transcriptional difference in the mutant SM comparing to its parental strain S determined by microarray.

  Function class                      Gene name         Gene function                                       Fold change
  ----------------------------------- ----------------- --------------------------------------------------- -------------
  Target gene                         *Cj0440c*         Putative transcriptional regulator                  -24.3
  Cell motility/signal transduction   *Cj1339c/flaA*    Flagellin                                           2.1
                                      *Cj1338c/flaB*    Flagellin                                           -3.5
                                      *Cj1729c/flgE2*   Flagellar hook protein FlgE                         -2.2
                                      *Cj0887c/flgL*    Flagellar hook-associated protein FlgL              -2.4
                                      *Cj1466/flgK*     Flagellar hook-associated protein FlgK              -3.3
                                      *Cj0043/flgE*     Flagellar hook protein                              -3.5
                                      *Cj1462/flgI*     Flagellar basal body P-ring protein                 -3.0
                                      *Cj0698/flgG*     Flagellar basal body rod protein FlgG               -3.2
                                      *Cj0687c/flgH*    Flagellar basal body L-ring protein                 -3.2
                                      *Cj0697/flgG2*    Flagellar basal-body rod protein                    -3.6
                                      *Cj0041/fliK*     Putative flagellar hook-length control protein      -4.5
  Carbohydrate metabolism             *Cj1327/neuB2*    *N*-acetylneuraminic acid synthetase                -3.1
                                      *Cj1328/neuC2*    UDP-*N*-acetylglucosamine 2-epimerase               -2.4
  Amino acid/energy metabolism        *Cj1293/pseB*     UDP-GlcNAc-specific C4,6 dehydratase/C5 epimerase   -2.2
                                      *Cj1294/pseC*     C4 aminotransferase specific for PseB product       -2.5
  Hypothetical proteins               *Cj1026c*         Putative lipoprotein                                -2.1
                                      *Cj1242*          Hypothetical protein                                -2.3
                                      *Cj1632c*         Putative periplasmic protein                        5.7

Only flaA and Cj1632c were up-regulated

.

###### 

Transcriptional difference in the mutant RM comparing to its parental strain R determined by microarray.

  Function class                      Gene name        Gene function                                   Foldchange
  ----------------------------------- ---------------- ----------------------------------------------- ------------
  Target gene                         *Cj0440c*        Putative transcriptional regulator              -35.2
  Cell motility/signal transduction   *Cj1338c/flaB*   Flagellin                                       -2.3
                                      *Cj0547/flaG*    Flagellar protein FlaG                          -2.3
                                      *Cj0548/fliD*    Flagellar capping protein                       -2.1
                                      *Cj0042/flgD*    Flagellar basal body rod modification protein   -2.7
  Energy metabolism                   *Cj1385/katA*    Catalase                                        -2.5
  Hypothetical proteins               *Cj1464/flgM*    Hypothetical protein                            -4.4
                                      *Cj1465*         Hypothetical protein                            -3.8
                                      *Cj1242*         Hypothetical protein                            -2.0
                                      *Cj0391c*        Hypothetical protein                            -2.1

![**Significant genes in *Cj0440c*-inactivated mutants and their relationship based on KEGG and STRING protein network analysis**. Green arrow and red arrow were genes down-regulated and up-regulated in SM, respectively. Genes with blue arrow were down-regulated in RM. The yellow double sided arrow means positive relationship between these genes and green double sided arrow means negative relationship between these genes.](fmicb-08-00729-g001){#F1}

A flagellin gene (*flaA*) and a gene (*Cj1632c*) encoding a putative periplasmic protein were up-regulated in SM as compared to S (indicated by red arrows in **Figure [1](#F1){ref-type="fig"}**). Among the down-regulated genes in SM (indicated by green arrows in **Figure [1](#F1){ref-type="fig"}**), 10 genes (*flaB*, *flgE*, *flgE2*, *flgG*, *flgG2*, *flgH*, *flgI*, *flgK*, *flgL*, and *fliK*) are possible involve in flagellar assembly; 2 genes (*pseB* and *pseC*) in carbohydrate metabolism; 2 genes (*neuB~2~* and *neuC*) in surface glycoprotein metabolism.

None of the genes were up-regulated genes were found in RM when compared the expression of different genes with R. Eleven down regulated genes in RM (indicated by blue arrows in **Figure [1](#F1){ref-type="fig"}**) are flagellar associated genes (*flgD*, *fliD*, *flaG* and *flaB*), a catalase encoding gene (*katA*) and four genes with unknown function (*flgM*, *Cj1465*, *Cj0391*, and *Cj1242*).

When submitted to STRING 9.05 and KEGG pathway analysis, the result showed that 10 flagellar genes were interacted with other down-regulated genes (*pseB*/*C*, *neuB~2~*/*C2* and *Cj1026c*) (**Figure [1](#F1){ref-type="fig"}**).

The transcriptional change of several representative genes detected in microarray was validated by qRT-PCR. The similar change of the selected genes was found both in microarray and qRT-PCR (**Figure [2](#F2){ref-type="fig"}**).

![**Confirmation of transcriptional change of target genes in the mutants and the parental strains by qRT-PCR. (A)** Fold change of six genes in SM versus S; **(B)** Fold change of four genes in RM versus R.](fmicb-08-00729-g002){#F2}

The microarray data obtained in this study have been deposited in the NCBI Gene Expression Omnibus database^[2](#fn02){ref-type="fn"}^ and assigned accession numbers GSE49255 (RM&R) and GSE49255(SM&S).

Antimicrobial Susceptibility of *Cj0440c* Mutants
-------------------------------------------------

As shown in **Table [4](#T4){ref-type="table"}**, there was no significant difference between MIC of nine antimicrobial agents in *Cj0440c* mutants (SM and RM) comparing to their parental strains (S and R). Inactivation of *Cj0440c* did not affect antimicrobial susceptibility of *C. jejuni*.

###### 

Minimum inhibitory concentration (MIC) of *Cj0440c* mutant strains and parental strains to different drugs.

  Strains   MIC to different drugs (μg/mL)                                               
  --------- -------------------------------- ----- -------- ----- ------- --- ----- ---- ---
  S         1                                4     0.0625   0.5   0.125   2   0.5   16   2
  SM        1                                4     0.0625   0.5   0.125   2   0.5   16   1
  R         256                              256   32       0.5   0.125   2   0.5   16   2
  RM        256                              256   32       0.5   0.125   2   0.5   16   1

S was

C. jejuni

NCTC 11168; SM was Cj0440c deletion mutant of S; R was Erythromycin resistant strain selected from

C. jejuni

NCTC 11168; RM was Cj0440c deletion mutant of R. The drugs included erythromycin (ERY), tylosin (TYL), azithromycin (AZM), tetracydine (TET), ciprofloxacin (CIP), chloramphenicol (CHL), gentamicin (GEN), ceftriaxone (CRO) and olaquindox (OLA)

.

Flagella Presence and Length
----------------------------

The electron micrographs of all tested strains were shown in **Figure [3](#F3){ref-type="fig"}**. The results showed that parental strains (S and R) had long, spiral and complete flagella filaments in two sides (**Figures [3A,C](#F3){ref-type="fig"}**). However, SM had shorter filaments in only one side (**Figure [3B](#F3){ref-type="fig"}**). No filaments of RM were detected in RM (**Figure [3D](#F3){ref-type="fig"}**). These findings indicated that *Cj0440c* may affect the formation of flagella in *C. jejuni.*

![**Flagella morphology of S** **(A)**, SM **(B)**, R **(C)**, and RM **(D)** under transmission electron microscope. The magnification used for TEM images in the captionis are 1 μm.](fmicb-08-00729-g003){#F3}

*In Vitro* Growth of *Cj0440c* Mutants
--------------------------------------

Growth kinetics of *Cj0440c* mutants (SM and RM) and their parental strains (S and R) were determined in MH broth. No significant difference in growth rate was observed between SM and S. The RM exhibited slower growth rate compared to its parental R, however, the difference was not significant (**Figure [4](#F4){ref-type="fig"}**).

![**The growth curve of *Cj0440c* mutants (SM and RM) and their parental strains (S and R)**.](fmicb-08-00729-g004){#F4}

*In Vivo* Colonization of *Cj0440c* Mutants
-------------------------------------------

To determine the colonization capacity, broiler chickens were infected individually with four *C. jejuni* strains (S, R, SM and RM). All the strains were able to colonize in chicken intestinal tract, albeit at different rate. Comparing with the parental strains (S or R), the *Cj0440c* mutants (SM and RM) showed a significant reduction in colonization on 12 days' post-inoculation (**Figure [5](#F5){ref-type="fig"}**).

![**Single colonization of four *C. jejuni* strains in chickens after oral inoculation. (A)** Colonization of S and SM; **(B)** Colonization of R and RM. The asterisk (^∗∗^) represent statistically significant difference with *P* ≤ 0.01 comparing with parental strains, respectively.](fmicb-08-00729-g005){#F5}

When the two pairs of *C. jejuni* strains (SM&S and RM&R) were infected chickens with one pair at a time, *Cj0440c* mutants (SM and RM) exhibited lower colonization level compared to their parental strains (S and R) after 9 days' post-inoculation (**Figure [6](#F6){ref-type="fig"}**).

![**Competitive colonization of *Cj0440c* mutants with their patent strains (SM&S and RM&R). (A)** Competitive colonization of the pair of SM&S; **(B)** Competitive colonization of the pair of RM&R. The asterisk (^∗∗^) represent statistically significant difference with *P* ≤ 0.01 comparing with parental strains, respectively.](fmicb-08-00729-g006){#F6}

Discussion
==========

*Campylobacter jejuni* is a very common foodborne pathogen in the developed world. Its biology and pathogenicity is largely unknown ([@B54]). *Cj0440c* is a putative transcriptional regulator and an increased transcriptional level expression was detected in the erythromycin-resistant *C. jejuni* ([@B22]). The gene may encode a TENA/THI-4/PQQC family protein. TENA is one of a number of proteins that enhance the expression of extracellular enzymes (e.g., alkaline protease, neutral protease and levansucrase) ([@B37]). The extracellular enzymes may be regulated by the master regulator of flagellar genes (e.g., *flhDC*) ([@B6]). THI-4 protein is involved in thiamine biosynthesis ([@B1]). This family also includes bacterial coenzyme pyrroloquinoline quinone (PQQ) synthesis protein C (PQQC) proteins. PQQ is the prosthetic group of several bacterial enzymes, including methanol dehydrogenase of methylotrophs and the glucose dehydrogenase ([@B47], [@B48]). In *E. coli*, PQQ biosynthesis may be affected by *tldD* gene which encodes a peptidase involved in processing of small peptides ([@B23]). The *tldD* may lead to chromosomal DNA relaxation and subsequent derepression of *cdtB* and *lgeR* which may regulate the expression of some flagellar genes ([@B19]). Therefore, the TENA/THI-4/PQQC family may have some indirect relationship with flagellar genes.

The flagella formation plays an important role in the pathogenesis of *Campylobacter* including motility, microcolony formation, biofilm formation, autoagglutination, protein secretion, adherence to host cell, and host invasion ([@B17]; [@B15]). The major groups of down-regulated genes in *Cj0440c* mutants (SM and RM) were involved in flagellar assembly, including 11 genes (*flaB*, *flgE*/*E2*/L/K/H/*G*/*G2*/*I*, *flgK*, *flgL*, *fliK*) in SM and 4 genes (*flaB/G*, *flgD*, *fliD*) in RM (**Figure [1](#F1){ref-type="fig"}**). The down-regulation of those flagella-associated genes in *Cj0440c* mutants can reasonably explain why SM and RM lose one or two sides of filament. The reduced colonization of *Cj0440c* mutants may result from the down-regulation of flagella genes.

A second group of genes (*pseB, pseC, neuB2* and *neuC2*) down-regulated in SM were involved in *O*-linked glycosylation which was also essential for flagellin assembly. The *pseB/C* in *C. jejuni* contribute in glycosylation modifications of flagellin, often by non-specifically modifying the surface-exposed Thr, Ser, and Tyr residues of filament proteins FlaA and FlaB ([@B10]). While *neuB2/C2* requires in *O*-linked glycosylation which may contribute to flagella antigen diversity of *Campylobacter* ([@B31]; [@B45]; [@B46]). The down-regulation of these glycosylation-associated genes in SM suggested that *Cj0440c* may play an important role in flagella assembly.

Several hypothetical genes (*Cj1026c, Cj1242, Cj1464, Cj1465* and *Cj0391c*) were down-regulated in SM or RM. The Cj1026c (FlgP) was essential for motility of *C. jejuni* and possible encode the promoter of *flaG* ([@B44]). The Cj1464 (FlgM) may regulate temperature-dependent FlgM/FliA complex formation and flagella length of *C. jejuni* ([@B52]). The *Cj0391c* generally co-expressed with flagella-associated genes and involved in biofilm formation of *Campylobacter* ([@B27]). The down-regulation of these genes suggested that *Cj0440c* may be closely associated with flagella biosynthesis and assembly.

All our data showed that *Cj0440c* may have close relationship with flagella biosynthesis and assembly, however, the precise role of *Cj0440c* in flagella formation pathway is yet to be determined. Flagellar biogenesis in *C. jejuni* requires three distinct sigma factors, including σ^80^, σ^54^ (or RpoN) and σ^28^ (or FliA) ([@B35]; [@B2]). The FlgS/FlgR two-component system is required for transcription of the RpoN regulon ([@B26]). The FliK likely part of a negative feedback loop that turns off expression of σ^54^-dependent genes ([@B40]; [@B28]). The FlgM (anti σ^28^) may negatively regulate the class III motility genes ([@B50]). The present study showed that the transcription of *fliK* was down-regulated in SM and the transcription of *flgM* (*Cj1464*) was down-regulated in RM. The down-regulation of *fliK* and *flgM* can influence the down-regulation of class II and class III motility. The roles of *Cj0440c* on flagellar genes are complex and further investigations are required.

The transcriptional change of majority parts of the genes was similar in both SM and RM except for few differences. The *flaA* and *Cj1632c* were up-regulated and *O*-linked glycosylation was down-regulated only in SM, while *katA*, encoding a sole catalase, was down-regulated in RM but not in SM. The flagellar filaments of *Campylobacter* spp. were composed primarily by FlaA and FlaB flagellin ([@B16]). The *flaA* was merely up-regulated in SM but *flaB* was down-regulated in both SM and RM. Findings of our study suggested that that the role *Cj0440c* on transcription of FlaA and FlaB flagellin are different in Ery^s^ and in Ery^r^ *C. jejuni*. The *katA* involves in oxidative stress and ROS defense which was essential for intra-macrophage persistence and environmental stress survival of *Campylobacter* ([@B11]; [@B7]; [@B49]; [@B12]). The down-regulation of *katA* in RM suggested that *Cj0440c* may interact with *katA* to improve their survival capacity in environmental stress.

The macrolide-resistance in *C. jejuni* generally suffered a fitness cost, however, several other factors may compensate the adaptation weakness ([@B4]; [@B30]; [@B36]; [@B20], [@B22]; [@B32]). Our previous study showed that *Cj0440c* was over-expressed in the Ery^r^ *C. jejuni* ([@B22]). The result from the present study suggests that *Cj0440c* plays a role in compensating the fitness cost of erythromycin resistance through the positive relationship with flagellar and other related genes.

Conclusion
==========

*Cj0440c* regulates expression of genes involved in flagella biosynthesis and assembly which consequently affects the growth or colonization of *C. jejuni in vitro* and *in vivo* environment.
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